Stocktoria
Guardian Pharmacy Services, Inc. GRDN
NYSE · stock · Retail-Drug Stores and Proprietary Stores · website · IPO 2024-09-26
Guardian Pharmacy Services, Inc. financials (annual)
Bars are annual figures from 2024 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | $1.4B | $1.2B |
| Gross profit | $292.7M | $244.4M |
| SG&A expense | $220.0M | $307.3M |
| Operating income | $72.7M | -$62.9M |
| Income tax | $24.5M | $4.6M |
| Net income | $49.2M | -$110.0M |
| Operating cash flow | $100.3M | $58.0M |
| Cash & equivalents | $65.6M | $4.7M |
| Inventory | $43.4M | $40.5M |
| Total assets | $412.7M | $320.8M |
| Total liabilities | $194.7M | $170.8M |
| Shareholders' equity | $217.9M | $150.0M |
Growth · year-over-year · Revenue CAGR 17.9%
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue growth | +17.9% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.